by Alexis DUPORT | 30 Sep, 2010 | Gènéthique informs you
In the occasion of the revision of the law of bioethics, Le Quotidien du Médecin opened its newspaper to Dr Sylvie Epelboin, gynaecologist co-responsible of the centre of medical assistance to procreation (MAP) of the hospital Bichat-Claude-Bernard of Paris, so that...
by Alexis DUPORT | 30 Sep, 2010 | Gènéthique informs you
On 14th October 2010, the administrative court of Paris rejected the resort en illegality introduced in 2008 by the Jérôme Lejeune Foundation against the Agency of Biomedicine (ABM) within the framework of an authorisation of research on human embryonic stem cells....
by Alexis DUPORT | 30 Sep, 2010 | Gènéthique informs you
The Parliamentary Assembly of the Council of Europe (PACE) rejected on 7th October 2010, the resolution project by Christine McCafferty. She opposed the right of conscientious objection of health professionals, especially for “reproductive health”, i.e....
by Alexis DUPORT | 31 Aug, 2010 | Gènéthique informs you
On 23rd August 2010, the judge Royce Lamberth of Washington federal court suspended by interim order the federal financing of the research on human embryonic stem cells. Prohibited by George W. Bush, this financing had been authorised by an order of Barack Obama on...
by Alexis DUPORT | 31 Aug, 2010 | Gènéthique informs you
Geron Corporation announced to have been authorised by the Food and Drug Administration (FDA) to carry on the first clinical trials on man with a line of human embryonic stem cells. It deals with a phase I trial on patients with lesions of spinal cord. The treatment,...